大范围T1a声门癌行I型或II型声带切除术或放疗后的嗓音
该非随机回顾性队列研究纳入172例肿瘤累及超过三分之二单侧膜性声带的T1a声门癌患者,分别接受I型声带切除术(n=56)、II型声带切除术(n=59)或放疗(n=57)。治疗后6个月放疗组嗓音结局显著优于C1和C2组,C1组显著优于C2组;治疗后24个月C1组显著优于放疗和C2组,而放疗与C2组无显著差异。作者认为C2与放疗嗓音结局相当,C1优于放疗,C1和C2可作为大范围T1a声门癌的治疗选择。
要点
- 治疗后6个月,放疗组嗓音结局显著优于C1组和C2组(P < .05)。
- 治疗后6个月,C1组嗓音结局显著优于C2组(P < .05)。
- 治疗后24个月,C1组嗓音结局显著优于放疗组和C2组(P < .05)。
核心结论
- II型声带切除术后的嗓音结局与放疗相当;I型声带切除术的嗓音结局优于放疗;I型和II型声带切除术可作为大范围T1a声门癌的治疗选择。
研究设计与样本
- 非随机回顾性队列研究,在三级转诊中心开展,共纳入172例肿瘤累及超过三分之二单侧膜性声带的T1a声门癌患者,其中I型声带切除术组(C1组)56例、II型声带切除术组(C2组)59例、放疗组(RT组)57例。
主要发现
- 治疗前各组嗓音结局无显著差异(P > .05)。
- 治疗后6个月,RT组嗓音结局显著优于C1组和C2组(P < .05);C1组嗓音结局显著优于C2组(P < .05)。
- 治疗后24个月,C1组嗓音结局显著优于RT组和C2组(P < .05);RT组与C2组无显著差异(P > .05)。
关键数值与推荐
- 评估工具包括GRBASI(评分、粗糙度、气息声、无力、紧张度、不稳定性)、视频喉频闪喉镜、嗓音障碍指数-30、声学分析(含F0、jitter、shimmer、噪谐比、倒谱峰值突出度及连续言语的倒谱频谱嗓音障碍指数)和空气动力学分析,于治疗前及治疗后6个月和24个月进行。
临床怎么用
- 作者认为,I型和II型声带切除术可作为大范围T1a声门癌的治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: T1a glottic cancer can be treated with transoral laser microsurgery (TLM) or radiation therapy (RT). Dysphonia is the major disadvantage of TLM, and preservation of voice appears to be the best advantage of RT compared to TLM. Studies on voice outcomes of both options gave conflicting results, but there is a tendency toward better voice outcome after TLM compared to the past. STUDY DESIGN: Nonrandomized retrospective cohort study. SETTING: Tertiary referral center. METHODS: In total, 172 patients with a cancer lesion involving more than two-thirds of 1 membranous vocal fold underwent cordectomy type I (n = 56) (C1 group) or type II (n = 59) (C2 group) or RT (n = 57) (RT group). GRBASI (grade, roughness, breathiness, asthenia, strain, instability), videolaryngostroboscopy, Voice Handicap Index-30, acoustic analysis including F0, jitter, shimmer, noise to harmonic ratio, cepstral peak prominence, and cepstral spectral index of dysphonia using running speech, and aerodynamic analysis were performed before treatment and 6 and 24 months after treatment. RESULTS: Study groups did not differ significantly on pretreatment voice outcomes (P > .05). The RT group had significantly better voice outcomes at 6 months posttreatment compared to the C1 and C2 groups (P < .05). The C1 group had significantly better voice outcomes at 6 months posttreatment compared to the C2 group (P < .05). The C1 group had significantly better voice outcomes at 24 months posttreatment compared to the RT and C2 groups (P < .05). The RT and C2 groups did not differ significantly at 24 months posttreatment (P > .05). CONCLUSION: Voice outcomes after C2 are equal to RT. C1 has better voice outcomes than RT. C1 and C2 can be the treatment of choice for large T1a glottic cancers.
引用
- Yılmaz T. Voice After Cordectomy Type I or Type II or Radiation Therapy for Large T1a Glottic Cancer. Otolaryngol Head Neck Surg. 2023. PMID: 35943800. doi:10.1177/01945998221117453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。